16. • 1-Reducing dose of Gondatrophins
• 2-using GNRH antagonist
• 3- reducing dose of HCG triggering
wael Naeem 16
17. • 4- Avoiding use of HCG for triggering …
• 5- Alternatives for triggering .
• 6- avoiding use of HCG for luteal phase
support
• 7- IVM
wael Naeem 17
23. •3. Avoid:
• a. Strenuous exercise
• b. Sexual intercourse {fear of injury or torsion
of hyperstimulatedovaries}.
• c. Complete bed rest {Increase DVT}
wael Naeem 23
24. • 4. Urgent clinical review:
• a. increasing severity of pain
• b. increasing abdominal distension
• c. shortness of breath
• d. reduced u output
wael Naeem 24
25. • III. Analgesia:
• Paracetamol or codeine
• NSAID should not be used
wael Naeem 25
26. • IV. Continue progesterone luteal support
but hCG luteal support is inappropriate.
wael Naeem 26
27. V. Severe OHSS
• 1. Thromboprophylaxis with LMWH.
The duration individualized, taking into account
risk factors whether or not conception occurs.
• 2. Paracentesis of ascitic fluid
carried out on an outpatient basis by the
abdominal or transvaginalroute under
ultrasound guidance.
wael Naeem 27
28. VII. Review and monitoring:
• Urgently
if symptoms or signs of worsening
• In the absence of these
every 2–3 days .
• Baseline laboratory investigations
repeated if severity is thought to be worsening.
Hct
useful guide to the degree of intravascular volume
depletion.
wael Naeem 28
29. S & S of worsening OHSS
• 1.increasing abdominal distension and pain
• 2.shortness of breath
• 3.tachycardia or hypotension
• 4.reduced urine output (≤ 1000 ml/24 h)
• 5.positive fluid balance (≥1000 ml/24 h)
• 6.weight gain and increased abdominal girth
• 7.increasing haematocrit(≥ 0.45).
wael Naeem 29
30. Inpatient management
Indication
• 1.unable to achieve satisfactory pain control
• 2.unable to maintain adequate fluid intake due
to nausea
• 3.show signs of worsening OHSS despite
outpatient intervention
• 4.unable to attend for regular outpatient follow-
up
• 5.have critical OHSS.
wael Naeem 30